Loading…
Viral and Cellular Determinants of the Hepatitis C Virus Envelope-Heparan SulfateInteraction
Cellular binding and entry of hepatitis C virus (HCV) are the first steps of viral infection and represent a major target for antiviral antibodies and novel therapeutic strategies. We have recently demonstrated that heparan sulfate (HS) plays a key role in the binding of HCV envelope glycoprotein E2...
Saved in:
Published in: | Journal of virology 2006-11, Vol.80 (21), p.10579-10590 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Cellular
binding and entry of hepatitis C virus (HCV) are the first steps of
viral infection and represent a major target for antiviral antibodies
and novel therapeutic strategies. We have recently demonstrated that
heparan sulfate (HS) plays a key role in the binding of HCV envelope
glycoprotein E2 to target cells (Barth et al., J. Biol. Chem.
278:
41003-41012, 2003). In this study, we characterized
the HCV-HS interaction and analyzed its inhibition by antiviral host
immune responses. Using recombinant envelope glycoproteins, virus-like
particles, and HCV pseudoparticles as model systems for the early steps
of viral infection, we mapped viral and cellular determinants of HCV-HS
interaction. HCV-HS binding required a specific HS structure that
included N-sulfo groups and a minimum of 10 to 14 saccharide subunits.
HCV envelope binding to HS was mediated by four viral epitopes
overlapping the E2 hypervariable region 1 and E2-CD81 binding domains.
In functional studies using HCV pseudoparticles, we demonstrate that
HCV binding and entry are specifically inhibited by highly sulfated HS.
Finally, HCV-HS binding was markedly inhibited by antiviral antibodies
derived from HCV-infected individuals. In conclusion, our results
demonstrate that binding of the viral envelope to a specific HS
configuration represents an important step for the initiation of viral
infection and is a target of antiviral host immune responses in vivo.
Mapping of viral and cellular determinants of HCV-HS interaction sets
the stage for the development of novel HS-based antiviral strategies
targeting viral attachment and
entry. |
---|---|
ISSN: | 0022-538X 1098-5514 |
DOI: | 10.1128/JVI.00941-06 |